MedTrace Logo

Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients

NCT01113853 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2010-05-03

No results posted yet for this study

Summary

Previous studies have demonstrated that exhaled nitric oxide can be useful to monitor the efficacy of anti-inflammatory treatment as well as to predict a risk of asthma relapse in asthmatic patients.

The aim of the present study is to evaluate the time course of exhaled nitric oxide in mild asthmatic patients, stopping regular treatment with inhaled corticosteroids, if it is possible, in relationship with symptoms and lung function.

Conditions

Sponsors & Collaborators

  • Azienda Ospedaliera Universitaria Policlinico

    collaborator OTHER

  • Universita di Verona

    lead OTHER

Principal Investigators

  • Giorgio L Piacentini, MD · Universita di Verona

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Completion
2010-01-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01113853 on ClinicalTrials.gov